RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.86B
AUM Growth
+$1.46B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
83
New
Increased
Reduced
Closed

Top Buys

1
+$163M
2
+$141M
3
+$105M
4
LENZ
LENZ Therapeutics
LENZ
+$93.3M
5
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
+$71M

Top Sells

1
+$704M
2
+$164M
3
+$94M
4
ALPN
Alpine Immune Sciences Inc
ALPN
+$93.6M
5
INBX
Inhibrx, Inc. Common Stock
INBX
+$73.2M

Sector Composition

1 Healthcare 99.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$91.9M 1.17%
2,629,837
-2,094,370
27
$83.8M 1.07%
3,282,180
+827,647
28
$79.8M 1.02%
1,000,000
29
$71M 0.9%
+3,289,119
30
$70M 0.89%
+2,333,000
31
$66.6M 0.85%
6,251,714
+664,381
32
$64.7M 0.82%
1,510,362
+1,023,530
33
$62.6M 0.8%
4,850,984
+1,672,508
34
$62.1M 0.79%
+4,413,150
35
$61.3M 0.78%
+1,397,433
36
$60.5M 0.77%
14,932,063
37
$60.3M 0.77%
4,417,259
38
$57.7M 0.73%
4,330,446
+904,160
39
$54.6M 0.69%
204,500
40
$53.9M 0.69%
1,137,444
41
$50.5M 0.64%
+828,380
42
$46.3M 0.59%
3,083,430
43
$45.9M 0.58%
+6,045,351
44
$45.7M 0.58%
6,809,404
45
$39.9M 0.51%
4,878,000
46
$39.8M 0.51%
6,144,881
47
$37.3M 0.48%
2,122,465
48
$36M 0.46%
13,150,849
49
$34.4M 0.44%
4,810,508
50
$31.2M 0.4%
10,872,503
-7,600,000
1
2
3 4